The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of anti-EGFR rechallenge therapy with panitumumab driven by circulating tumor DNA molecular selection in metastatic colorectal cancer: The CHRONOS trial.
 
Andrea Sartore-Bianchi
Honoraria - Amgen; Bayer; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Sanofi
 
Filippo Pietrantonio
Honoraria - Amgen; Bayer; Lilly; Merck; Sanofi; SERVIER
Research Funding - AstraZeneca; Bristol-Myers Squibb
 
Sara Lonardi
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Incyte; Lilly; Merck Serono; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Pierre Fabre; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Benedetta Mussolin
No Relationships to Disclose
 
Francesco Rua
No Relationships to Disclose
 
Elisabetta Fenocchio
Consulting or Advisory Role - Merck Serono
 
Alessio Amatu
Consulting or Advisory Role - Bayer; Roche
 
Salvatore Corallo
No Relationships to Disclose
 
Chiara Manai
No Relationships to Disclose
 
Federica Tosi
No Relationships to Disclose
 
Paolo Manca
Patents, Royalties, Other Intellectual Property - I have a patent for a method for the identification of gene panels optimal for TMB estimation (Inst)
 
Francesca Daniel
No Relationships to Disclose
 
Valter Torri
No Relationships to Disclose
 
Angelo Vanzulli
Stock and Other Ownership Interests - Roche
 
Giovanni Cappello
No Relationships to Disclose
 
Caterina Marchiò
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Roche
 
Anna Sapino
No Relationships to Disclose
 
Silvia Marsoni
No Relationships to Disclose
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Alberto Bardelli
Stock and Other Ownership Interests - Neophore; Phoremost
Honoraria - Guardant Health; Illumina; Merck; Mundipharma; Novartis; Roche Pharma AG
Consulting or Advisory Role - Biocartis; Horizon Discovery; Neophore
Research Funding - Merck; Neophore
Travel, Accommodations, Expenses - Biocartis